General
Pfizer’s COVID vaccine success is worth an extra $14 billion to the US pharma giant
The success of its COVID vaccine, and the challenges faced by some of its rivals, look set to earn US pharmaceutical giant Pfizer at least an extra $US11 billion ($14.2 billion) in revenue this year.
Key points:
- Pfizer has raised its 2021 revenue forecasts for COVID vaccine sales by 73 per cent
- Click here to view the original article.
Continue Reading
-
Noosa News22 hours agoTributes for woman allegedly mowed down on footpath in Maroochydore; Guilherme Dal Bo charged
-
General15 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General19 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
General8 hours agoThe one tweak that could grow your super by $200,000